Trademarkia Logo

Canada

C$
Trademark Search in Canada
XERVYTEG

View On IC.GC.CA

XERVYTEG
FORMALIZED

on 14 May 2025

Last Applicant/ Owned by

MAAT PHARMA

70 Avenue Tony GarnierF-69007 LYON

FR

Serial Number

2398906 filed on 21st Mar 2025

XERVYTEG

Trademark usage description

pharmaceutical and biopharmaceutical products and preparations for the medical treatment of gastrointestinal diseases and disorders emanating from mic Read More

Classification Information

Class [005]
Pharmaceutical and biopharmaceutical products and preparations for the medical treatment of gastrointestinal diseases and disorders emanating from microbiota dysfunction; pharmaceutical and biopharmaceutical products and preparations used for the treatment of cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; pharmaceuticals used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases.

Classification kind code

12

Class [010]
Medical and surgical apparatus and instruments; drug delivery devices, including medical apparatus and instruments for administration of pharmaceutical and biopharmaceutical products and preparations; drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, in the nature of a kit comprising a prefilled suspension bag and administration tube set.

Classification kind code

12

Mark Details

Serial Number

2398906

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 257
on 15th May 2025		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 14th May 2025		Created
Submitted for opposition 31
on 14th May 2025		Formalized
Submitted for opposition 30
on 21st Mar 2025		Filed
Submitted for opposition 228
on 21st Mar 2025		International Registration